上海莱士：公司代理进口人血白蛋白产品以美元结算为主

Core Viewpoint - The company Shanghai Laishi indicated that its imported human albumin products are primarily settled in US dollars, and a rise in the value of the RMB could increase the company's net profit, assuming other variables remain constant [2]. Group 1 - The company primarily uses US dollars for settling its imported human albumin products [2]. - A stronger RMB could lead to an increase in net profit for the company [2].